Summary
This document is a guide that addresses the credibility issues within the digital health industry, particularly focusing on the importance of clinical rigor in digital health offerings. It outlines the significant growth in funding for digital health companies and the corresponding influx of products that may lack clinical validation. The guide emphasizes the need for buyers to demand better standards when evaluating digital health products. It provides practical advice on assessing vendors, including the importance of evidence-based practices, validation through peer-reviewed publications, and the use of gold-standard metrics. The document also discusses the necessity of a trustworthy ROI analysis and the role of HIPAA compliance in ensuring data protection. By understanding these key indicators, customers can make informed purchasing decisions that prioritize clinical quality and efficacy.
